Pediatric Allogeneic Bone Marrow Transplant for Acute Lymphoblastic Leukemia (ALL) using donor cells at Sheba Hospital- JCI accredited and Top-10 Hospitals 2026 by Newsweek

• Biochemical blood analysis
• Consultation with a hematologist
• Extended analysis of blood
• Bone marrow biopsy
• Сonsultation with an oncohematologist
• Сomprehensive diagnosis of Leukemia
• Cytogenetic study of the bone marrow
• Bone marrow puncture with cytogenetic analysis
• Bone marrow transplantation
• Autologous bone marrow transplantation
• Allogenic bone marrow transplantation from an unrelated donor
• Allogenic bone marrow transplantation from a related donor
• 3 meals per day by nutritionist
• 24-hr nurse services
• Electrocardiogram (ECG)
• Blood tests
• Chest X-ray
• Anti-HIV test
• Anti-HBC test
• Anti-HCVAb test
• Echocardiography
• Complete blood count (CBC)
• Biochemistry blood test
• PET/CT
• Consultation with an immunologist
• Consultation with a cardiologist
• Consultation with a pediatric hematologist
• Consultation with a pediatrician
• Сonsultation with an oncohematologist
• Head MRI
• Biopsy
• Complete blood count with cancer markers and a proteinogram

• 30 days in the hospital

• Transfer airport-clinic-airport

Pediatric Allogeneic Bone Marrow Transplant for Acute Lymphoblastic Leukemia (ALL) - Using donor cells
Sheba Medical Center – Advanced, Personalized Care for Children

Roughly two-thirds of pediatric transplants are allogeneic (using cells from a donor), which is the standard curative method for aggressive or relapsed ALL.
At Sheba Medical Center, we understand how overwhelming a diagnosis of Acute Lymphoblastic Leukemia (ALL) can be for both children and their families. Our mission is to provide not only the most advanced medical care available, but also reassurance, clarity, and compassionate support throughout every stage of treatment.

As a global leader in pediatric hemato-oncology, Sheba offers cutting-edge bone marrow transplantation (BMT) for children with ALL particularly in cases where the disease is high-risk, relapsed, or resistant to standard therapies.

When is a Bone Marrow Transplant Needed in ALL?

While many children with ALL respond very well to chemotherapy, some require a more intensive approach to achieve a lasting cure.

A bone marrow transplant may be recommended when:

The leukemia has relapsed
The disease is resistant to treatment
There are high-risk genetic features
A deeper, more durable remission is needed

In these situations, BMT replaces the diseased bone marrow with healthy stem cells helping rebuild a new immune system capable of eliminating leukemia cells.

A Personalized Treatment Strategy

Every child’s condition is unique. At Sheba, treatment decisions are made by a dedicated team of pediatric leukemia and transplant specialists who carefully tailor each plan.

Whenever possible, a matched sibling donor is used.
If no sibling match is available, we actively secure the most suitable donor using advanced matching technologies and global registries, including:

Matched unrelated donors from international donor programs
Haploidentical (half-matched) family donors, such as parents
Cord blood transplantation

Our state-of-the-art HLA and molecular laboratories ensure highly accurate matching, improving safety and transplant success.

Advanced Therapies for Better Outcomes

Sheba is at the forefront of innovation in pediatric ALL treatment, combining transplantation with the latest breakthroughs:

CAR-T cell therapy, often used before transplant in relapsed or refractory ALL to achieve remission
T-cell depletion and CD34+ selection reducing complications such as graft-versus-host disease
Access to international clinical trials and novel therapies

This integrated approach allows us to treat even the most complex cases successfully.

Leading Results in Pediatric ALL

Sheba’s outcomes for pediatric ALL are among the best internationally:

~70–85% success rates in children undergoing transplant in remission
Improved outcomes in relapsed cases through CAR-T integration
Strong long-term survival and quality of life

Our continuous research and clinical expertise ensure that every child benefits from the most advanced care available today.

Care That Supports the Whole Family

At Sheba, we treat more than the disease - we care for the child and their family as a whole. Children are treated in specialized, highly protected environments with advanced infection control, while families receive ongoing support, guidance, and clear communication.

Our team stays closely involved throughout the entire journey, ensuring each child is supported medically and emotionally on the path to recovery.

Why Families Choose Sheba for ALL Treatment
Global leader in pediatric leukemia and bone marrow transplantation
Expertise in high-risk and relapsed ALL
Ability to secure optimal donors even without a family match
Integration of CAR-T therapy and advanced cellular treatments
Multidisciplinary, patient-centered approach
Dedicated services for international families
A Message of Hope

For children facing Acute Lymphoblastic Leukemia, a bone marrow transplant can offer a real chance for cure. At Sheba Medical Center, we combine advanced science with compassionate care helping children overcome leukemia and move forward toward a healthy, hopeful future.

• Personal medical coordinator
• Medical travel arrangements — booking of air tickets and hotel rooms at special partner prices
• Patient advocacy during medical travel